Previsioni di mercato della bioproduzione in Medio Oriente e Africa fino al 2030 - Analisi regionale - per prodotto (prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri), applicazione (artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari, e altri), apparecchiature (apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)
Il passaggio alla produzione automatizzata di terapie cellulari rafforza il mercato della bioproduzione in Medio Oriente e Africa.
L\'automazione può offrire molti vantaggi agli sviluppatori di terapie cellulari, tra cui la riduzione del rischio di contaminazione, migliore consistenza e riduzione dei costi di produzione. Molte aziende hanno offerto dispositivi per consentire l’automazione, come il sistema Lonza Cocoon e CliniMACS Prodigy di Miltenyi, progettati per consentire l’automazione della maggior parte delle operazioni unitarie sequenziali per un processo CAR-T all’interno di un unico sistema. Un numero crescente di terapie cellulari ha spostato la produzione di prodotti di terapia cellulare da un piccolo volume a un grande volume in tutto il mondo. Inoltre, l’evoluzione della terapia cellulare, dal contesto accademico e clinico alla produzione e commercializzazione di massa, sta aumentando la domanda di automazione nel settore manifatturiero. Le crescenti attività di ricerca nel campo delle terapie cellulari hanno portato a un aumento della domanda di soluzioni di produzione avanzate. In considerazione di ciò, molti attori offrono prodotti per soddisfare le esigenze digitali dei ricercatori accademici e delle grandi aziende biotecnologiche. Ad esempio, nel maggio 2019, GE Healthcare ha lanciato l’applicazione web Chronicle per supportare il flusso di lavoro completo della terapia cellulare. Il software di automazione Chronicle è una soluzione digitale conforme alle buone pratiche di produzione (GMP) progettata per ottimizzare lo sviluppo e la produzione di processi di terapia cellulare complessi.
Le aziende stanno inoltre entrando in sviluppi strategici e tecnologici per l\'automazione nella terapia cellulare. Ad esempio, nel luglio 2020, Thermo Fisher Scientific Inc. e Lyell Immunopharma hanno collaborato per sviluppare e produrre processi per progettare terapie cellulari efficaci per i pazienti affetti da cancro. Nell’ambito di questa partnership, le aziende mirano a migliorare l’idoneità delle cellule T e a supportare lo sviluppo di una piattaforma integrata (sistema e software) conforme alle attuali buone pratiche di produzione (cGMP) insieme a reagenti, materiali di consumo e strumenti. Pertanto, si prevede che la crescente adozione dell’automazione tra i produttori di terapie cellulari guiderà il mercato.
Panoramica del mercato della bioproduzione in Medio Oriente e Africa
Il mercato della bioproduzione in Medio Oriente e Africa include un\'analisi a livello nazionale degli Emirati Arabi Uniti, dell\'Arabia Saudita, del Sud Africa e del resto del Medio Oriente e dell\'Africa. La crescita del mercato della bioproduzione può essere attribuita al cambiamento delle politiche governative, all’aumento dei partenariati pubblico-privato e al miglioramento delle infrastrutture sanitarie. Inoltre, la crescente domanda di terapie cellulari avanzate ed efficaci sta facilitando la crescita del mercato.
Secondo la Società Internazionale per la Farmacoeconomia e la Ricerca sui Risultati (ISPOR), le malattie cardiovascolari sono state la principale causa di morte in Arabia Saudita nel 2020, rappresentando il 45,7% di tutti i casi di morte. Inoltre, in Arabia Saudita vi è un’elevata prevalenza del diabete a causa di abitudini alimentari non salutari e stili di vita sedentari. Secondo l’IDF, il tasso di frequenza del diabete in Arabia Saudita variava dall’8% al 22% nel 2021. I fattori che contribuiscono maggiormente al diabete sono l’obesità, lo stile di vita non sano e la predisposizione genetica. Secondo un sondaggio a livello nazionale, nel 2022 l’Arabia Saudita aveva il 5,5% di prevalenza di malattie cardiovascolari. Pertanto, il crescente tasso di incidenza delle malattie cardiovascolari e del diabete in Arabia Saudita sta guidando la crescita del mercato della bioproduzione.
Previsioni e entrate del mercato della bioproduzione in Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato della bioproduzione in Medio Oriente e Africa
Il mercato della bioproduzione in Medio Oriente e Africa è classificato in prodotto, applicazione, attrezzatura, utente finale e paese.
In base al prodotto, il mercato della bioproduzione in Medio Oriente e Africa è segmentato in prodotti biologici e biosimilari, vaccini, terapie cellulari e genetiche, terapie con acidi nucleici e altri. Il segmento dei prodotti biologici e biosimilari ha detenuto la maggiore quota di mercato della bioproduzione in Medio Oriente e Africa nel 2022.
In termini di applicazione, il mercato della bioproduzione in Medio Oriente e Africa è segmentato in artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri. Il segmento del cancro ha detenuto la maggiore quota di mercato della bioproduzione in Medio Oriente e Africa nel 2022.
In base alle apparecchiature, il mercato della bioproduzione in Medio Oriente e Africa è suddiviso in apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori. Il segmento dei materiali di consumo e degli accessori ha detenuto la maggiore quota di mercato della bioproduzione in Medio Oriente e Africa nel 2022.
In termini di utente finale, il mercato della bioproduzione in Medio Oriente e Africa è classificato in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Il segmento delle aziende biofarmaceutiche deteneva la maggiore quota di mercato della bioproduzione in Medio Oriente e Africa nel 2022.
Per paese, il mercato della bioproduzione in Medio Oriente e Africa è segmentato in Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del Medio Oriente e dell\'Africa . L\'Arabia Saudita ha dominato la quota di mercato della bioproduzione in Medio Oriente e Africa nel 2022.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd e Bio-Rad Laboratories Inc. sono alcune delle aziende leader che operano nel mercato della bioproduzione in Medio Oriente e Africa.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Middle East & Africa Bioproduction Market
10.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Saudi Arabia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Saudi Arabia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Saudi Arabia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 South Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 South Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 South Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 South Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UAE: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 UAE: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 UAE: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 UAE: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1. Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioproduction Market Segmentation
Table 2. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. South Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. South Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 24. Recent Organic Growth Strategies in the Bioproduction Market
Table 25. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Middle East & Africa Bioproduction Market Segmentation, By Country
Figure 2. Middle East & Africa Bioproduction Market: Key Industry Dynamics
Figure 3. Middle East & Africa Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Middle East & Africa: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.